Print This Page Email This Page Share on LinkedIn Copyright Permissions Comment on This Story Custom Reprints Current Issue View Archives More Pharmaceuticals & Fine Chemicals Sun Pharma Acquires U.S. API FirmJohnson Matthey Completes Sale of Ceramic Insulator and Alumina BusinessesMcNeil and Sugar Group Settle Splenda SuitSAFC: The Age of the Blockbuster Drug has ‘Disappeared’Merck Adds to Biotech Center Related Stories DSM Enters U.S. Food Enzymes Market Via AcquisitionDSM Invests in Probiotics StartupDemand for Healthier Foods Stirs Up Growth in HydrocolloidsSuppliers Bite Into Trend to Reduce Trans FatsDSM Buys Enzymes Business

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

November 5, 2007

DSM Invests in Probiotics Start Up

Alex Scott

DSM says its subsidiary DSM Ventures and private equity firm Capital Resource Partners (Boston, MA) have each invested in Ganeden Biotech (Mayfield Heights, OH), a manufacturer of dietary supplements for digestive health. DSM and CSP have invested a combined...

This information is only available to
Chemical Week 24/7 members and subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not a Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive        access of the last 2 years        of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers